Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 828

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 828
---
 and issuable to the Investors pursuant to the Securities Purchase Agreement on NYSE American, the Board has determined that it is advisable and in the best interests of the Company to effectuate a reverse stock split of the common stock, par value $0.0001 per share, of the Company (the “ Company Common Stock ”), at a ratio of between 5:1 (five-to-one) and 100:1 (one hundred-to-one), as shall be determined by the Board immediately prior to the effectiveness of the Reverse Stock Split Amendment (as defined below), which shall include all registered, authorized, issued and outstanding shares of Company Common Stock (the “ Reverse Stock Split ”);

WHEREAS , in order to effectuate the Reverse Stock Split, the Company will amend its articles of incorporation accordingly (the “ Reverse Stock Split Certificate of Amendment ”);

WHEREAS , in connection with the Merger and pursuant to the Financing Documents, the Board has determined that it is advisable and in the best interests of the Company and its stockholders (the “ Company Stockholders ”) to file one or more registration statements (collectively, the “ Registration Statements ”) with the U.S. Securities and Exchange Commission (the “ SEC ”) to register for resale the maximum number of shares of Company Common Stock issuable upon conversion of the Series A Preferred Shares to be paid by the Company in the Merger pursuant to the Merger Agreement and issuable to the Investors pursuant to the Securities Purchase Agreement (together, the “ Share Issuances ”);

WHEREAS , the Board has declared it advisable and in the best interests of the Company and the Company Stockholders to ratify the approval of the terms of the Series A Preferred Shares to be paid by the Company in the Merger pursuant to the Merger Agreement and issuable pursuant to the Securities Purchase Agreement and to authorize and approve the filing of the Certificate of Designations of Rights and Preferences of the Series A Preferred Shares, substantially in the form attached hereto as Exhibit D (the “ Series A Certificate of Designations ”), with the Secretary of State of the State of Nevada;

WHEREAS , the Consenting Stockholders, upon the recommendation of the Board, deem it advisable and in the best interests of the Company and the Company Stockholders to file with the Secretary of State of the State of Nevada, the Series A Certificate of Designations, for the sole purpose of establishing the terms of the Series A Preferred Shares as in effect immediately prior to the Merger;

WHEREAS , as a condition to closing